A Phase I Trial of Autologous T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Anti-CD19 transduced T-cells (Primary) ; Cyclophosphamide
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 06 Jul 2021 Biomarkers information updated
- 14 Jun 2013 New source identified and integrated: Memorial Sloan-Kettering Cancer Center record.
- 13 Jun 2013 New trial record